Tracon Pharmaceuticals, Inc.·4

Feb 3, 7:55 PM ET

THEUER CHARLES 4

4 · Tracon Pharmaceuticals, Inc. · Filed Feb 3, 2023

Insider Transaction Report

Form 4
Period: 2023-02-01
THEUER CHARLES
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-02-01+332,000332,000 total
    Exercise: $1.70Exp: 2033-01-31Common Stock (332,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION